Literature DB >> 3100434

Human interleukin 2: molecular biology, physiology and clinical possibilities.

R Mertelsmann, K Welte.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3100434     DOI： 10.1016/S0171-2985(86)80121-8

Source DB:  PubMed          Journal:  Immunobiology        ISSN： 0171-2985            Impact factor:   3.144


× No keyword cloud information.
  10 in total

1.  The interleukin 2 gene is expressed in the syncytiotrophoblast of the human placenta.

Authors:  K D Boehm; M F Kelley; J Ilan; J Ilan
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

2.  Recombinant human interleukin-2-induced mitogenic proliferation of in vitro unstimulated bovine intestinal lymphocytes.

Authors:  A M Nagi; L A Babiuk
Journal:  Can J Vet Res       Date:  1989-01       Impact factor: 1.310

3.  Raised serum soluble interleukin-2 receptor concentrations in cystic fibrosis patients with and without evidence of lung disease.

Authors:  E Dagli; J A Warner; C R Besley; J O Warner
Journal:  Arch Dis Child       Date:  1992-04       Impact factor: 3.791

4.  Use of 2-hydroxypropyl-beta-cyclodextrin as a solubilizing and stabilizing excipient for protein drugs.

Authors:  M E Brewster; M S Hora; J W Simpkins; N Bodor
Journal:  Pharm Res       Date:  1991-06       Impact factor: 4.200

Review 5.  Cytokines in human milk: properties and potential effects upon the mammary gland and the neonate.

Authors:  A S Goldman; S Chheda; R Garofalo; F C Schmalstieg
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-07       Impact factor: 2.673

6.  Toxicity of local, continuous and cyclic, high-dose bladder perfusion with recombinant and natural interleukin-2 in advanced cancer of the urinary bladder.

Authors:  H Schwaibold; E Huland; H Heinzer; U Schwuléra; H Huland
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

7.  Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy.

Authors:  J B Hibbs; C Westenfelder; R Taintor; Z Vavrin; C Kablitz; R L Baranowski; J H Ward; R L Menlove; M P McMurry; J P Kushner
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

8.  Nickel antigen induces IL-2 secretion and IL-2 receptor expression mainly on CD4+ T cells, but no measurable gamma interferon secretion in peripheral blood mononuclear cell cultures in delayed type hypersensitivity to nickel.

Authors:  R Karttunen; S Silvennoinen-Kassinen; K Juutinen; G Andersson; H P Ekre; J Karvonen
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

9.  Combined interleukin 1/interleukin 2 therapy of mice injected with highly metastatic Friend leukemia cells: host antitumor mechanisms and marked effects on established metastases.

Authors:  V Ciolli; L Gabriele; P Sestili; F Varano; E Proietti; I Gresser; U Testa; E Montesoro; D Bulgarini; G Mariani
Journal:  J Exp Med       Date:  1991-02-01       Impact factor: 14.307

10.  Influence of tumour physico-chemical conditions on interleukin-2-stimulated lymphocyte proliferation.

Authors:  D A Loeffler; P L Juneau; S Masserant
Journal:  Br J Cancer       Date:  1992-10       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.